UnitedHealth Group Incorporated (NYSE:UNH – Get Free Report)’s stock price fell 10.2% during mid-day trading on Wednesday. The stock traded as low as $342.46 and last traded at $350.0950. Approximately 17,239,976 shares changed hands during trading, an increase of 139% from the average daily volume of 7,209,344 shares. The stock had previously closed at $389.68.
Top UnitedHealth Group Stories
Investors following UNH have been watching these stories:
- Positive Sentiment: UnitedHealth recently raised its 2026 adjusted earnings guidance for the third time, to at least $20.50 per share. Improved insurance margins and Optum’s scale offer potential support for longer-term growth. UnitedHealth Keeps Raising Guidance
- Negative Sentiment: CMS has proposed expanding Medicare Advantage audits and recovering overpayments dating back to 2018. The agency estimates the audits could recoup about $9 billion per payment year industry-wide; UnitedHealth’s potential share is unclear. The prospect of retroactive repayments is weighing on insurers’ outlooks. Why UnitedHealth and Other Medicare Advantage Insurers Are Falling
- Negative Sentiment: Political scrutiny is adding to the pressure: Sen. Elizabeth Warren called for breaking up healthcare conglomerates, including UnitedHealth, while Sen. Bernie Sanders renewed his push for Medicare for All. These proposals add uncertainty about the company’s business structure and future policy environment. Elizabeth Warren Targets CVS, UnitedHealth and Cigna
Analyst Upgrades and Downgrades
Several equities analysts have commented on the stock. Morgan Stanley increased their target price on shares of UnitedHealth Group from $529.00 to $531.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 27th. Sanford C. Bernstein reduced their price target on shares of UnitedHealth Group from $512.00 to $500.00 and set an “outperform” rating for the company in a report on Wednesday, October 14th. UBS Group restated an “outperform” rating on shares of UnitedHealth Group in a research note on Tuesday, October 13th. Wall Street Zen upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. Finally, TD Cowen restated a “hold” rating and issued a $402.00 target price on shares of UnitedHealth Group in a research note on Thursday, October 15th. Twenty investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $463.93.
Read Our Latest Report on UnitedHealth Group
UnitedHealth Group Price Performance
The stock has a market capitalization of $313.69 billion, a P/E ratio of 19.99, a PEG ratio of 1.49 and a beta of 0.51. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.66. The company has a fifty day simple moving average of $391.42 and a two-hundred day simple moving average of $366.73.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, beating the consensus estimate of $4.14 by $0.55. The company had revenue of $112.72 billion during the quarter, compared to analysts’ expectations of $111.31 billion. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The business’s revenue for the quarter was down .4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.59 EPS. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 20.61 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, December 7th will be issued a $2.32 dividend. The ex-dividend date of this dividend is Monday, December 7th. This represents a $9.28 annualized dividend and a dividend yield of 2.7%. UnitedHealth Group’s payout ratio is 53.00%.
Insider Activity
In other news, CEO Patrick Conway sold 1,169 shares of the firm’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the sale, the chief executive officer owned 15,328 shares of the company’s stock, valued at $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.19% of the stock is owned by company insiders.
Hedge Funds Weigh In On UnitedHealth Group
Large investors have recently added to or reduced their stakes in the company. BlackRock Inc. boosted its stake in shares of UnitedHealth Group by 4.6% during the 2nd quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock worth $31,946,594,000 after buying an additional 3,395,530 shares during the last quarter. State Street Corp grew its stake in UnitedHealth Group by 0.7% in the 2nd quarter. State Street Corp now owns 45,633,267 shares of the healthcare conglomerate’s stock valued at $18,966,555,000 after buying an additional 301,081 shares during the last quarter. Bank of America Corp DE lifted its holdings in UnitedHealth Group by 21.8% during the 1st quarter. Bank of America Corp DE now owns 11,713,684 shares of the healthcare conglomerate’s stock worth $3,169,606,000 after purchasing an additional 2,097,859 shares during the last quarter. Fisher Asset Management LLC increased its position in UnitedHealth Group by 19.2% during the third quarter. Fisher Asset Management LLC now owns 10,829,637 shares of the healthcare conglomerate’s stock worth $3,975,343,000 after acquiring an additional 1,747,368 shares during the period. Finally, Bank of New York Mellon Corp boosted its stake in shares of UnitedHealth Group by 6.1% in the second quarter. Bank of New York Mellon Corp now owns 10,704,994 shares of the healthcare conglomerate’s stock valued at $4,449,317,000 after buying an additional 616,723 shares during the period. Institutional investors own 87.86% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.
See Also
- Five stocks we like better than UnitedHealth Group
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
